HealthVC

HealthVC

Home
Podcast
Chat
Archive
Leaderboard
About
What LPs Are Asking About Healthtech Funds in 2025
A Playbook for Founders and Emerging Managers Who Want to Raise Real Capital in a Tighter Market
 • 
Martyn Eeles
Proprietary Deal Flow: The Quiet Engine of Top-Tier Venture Funds
In venture, the best deals don’t knock, they whisper. Here's how top funds source them before anyone else knows they exist.
 • 
Martyn Eeles
The Fine Print That Protects Millions: Why Covenants Matter in VC Deals
Unlock the key to safer investments and stronger founder relationships with this deep dive into venture covenants
 • 
Martyn Eeles
Blitzscaling: Speed, Uncertainty, and the High-Stakes Race for Market Dominance
What VCs in Life Sciences Can Learn from One of Tech’s Riskiest Growth Strategies
 • 
Martyn Eeles
Hockey Stick Growth in Life Sciences: The Dream, the Data, and the Discipline
Why explosive growth in life sciences looks different — and how great investors recognize it before it happens.
 • 
Martyn Eeles

May 2025

Inside the Mind of an Angel Investor
Discover how angel investors pick winners, why they matter more than ever, and what every founder should know before pitching.
 • 
Martyn Eeles
You Don’t Need Everyone—You Just Need the Right Slice
Why mass marketing is dead — and how carving up your audience leads to higher margins, better retention, and faster scale.
 • 
Martyn Eeles
1
Before You Expand, Read This: The Strategy Most Startups Overlook
Why Market Penetration Could Be the Smartest—and Fastest—Way to Grow in Health Tech
 • 
Martyn Eeles
B2B vs. B2C in Health Tech: Why Your Business Model Will Make or Break You
The hidden costs, sales traps, and scaling risks that every founder and investor should know—before the first pilot or product launch.
 • 
Martyn Eeles
Clawbacks in Venture Capital: The Hidden Clause That Protects LPs
A deep dive into the GP’s promise to give money back when things don’t go as planned.
 • 
Martyn Eeles
The Startup Factory Model: How Venture Studios Are Reshaping Innovation
Why this under-the-radar model could be the most efficient way to build companies—and how founders and investors alike can benefit.
 • 
Martyn Eeles

April 2025

© 2025 Martyn Eeles
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture